Form 8-K ENANTA PHARMACEUTICALS For: Aug 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Enanta Pharm (ENTA) Posts Mixed Q3 Results
August 11, 2014 9:23 AM EDTEnanta Pharm (NASDAQ: ENTA) reported Q3 EPS of $2.61, $0.94 better than the analyst estimate of $1.67. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $40.83 million.
For earnings history and earnings-related data on Enanta Pharm (ENTA) click here.
... More